Mirum Pharmaceuticals (MIRM) Return on Capital Employed (2019 - 2026)
Mirum Pharmaceuticals' (MIRM) quarterly Return on Capital Employed came in at 134.07% in Q1 2026, down 12026.0% year-on-year from N/an in Q1 2025, and down 3583.39% quarter-over-quarter from 3.64% in Q4 2025.
Mirum Pharmaceuticals (MIRM) Return on Capital Employed (2019 - 2026) Analysis & Trends
Mirum Pharmaceuticals' Return on Capital Employed history runs 8 years deep, the most recent figure standing at 134.07% for Q1 2026.
- On a quarterly basis, Return on Capital Employed fell 12026.0% year-over-year to 134.07% in Q1 2026; TTM through Mar 2026 was 134.07%, a 12026.0% decrease from a year earlier, with the FY2025 full-year figure at 4.02%, up 1245.0% from the prior year.
- Return on Capital Employed eased to 134.07% in Q1 2026 per MIRM's latest filing, from 3.64% in the prior quarter.
- Across five years, Return on Capital Employed topped out at 3.64% in Q4 2025 and bottomed at 134.07% in Q1 2026.
- The 5-year median for Return on Capital Employed is 19.96% (2024), against an average of 34.42%.
- Across the five-year window, Return on Capital Employed jumped 3521 bps in 2022 and sank 12026 bps in 2026, its largest moves.
- Year by year, Return on Capital Employed stood at 44.65% in 2022, then jumped by 56 bps to 19.44% in 2023, then climbed by 17 bps to 16.14% in 2024, then surged by 77 bps to 3.64% in 2025, then plunged by 3583 bps to 134.07% in 2026.
- Per Business Quant, the three latest MIRM Return on Capital Employed figures stand at 134.07% (Q1 2026), 3.64% (Q4 2025), and 7.02% (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -31.80% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 10.46% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -68.47% |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 21.10% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 10.19% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -68.84% |
| 10 | Mirum Pharmaceuticals | 6.73 Bn | 6.34 Bn | 131.08 Mn | -134.07% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -134.07% |
| Dec 31, 2025 | -3.64% |
| Sep 30, 2025 | -7.02% |
| Jun 30, 2025 | -10.13% |
| Mar 31, 2025 | -13.80% |
| Dec 31, 2024 | -16.14% |
| Sep 30, 2024 | -17.49% |
| Jun 30, 2024 | -19.93% |
| Mar 31, 2024 | -19.96% |
| Dec 31, 2023 | -19.44% |
| Sep 30, 2023 | -23.44% |
| Jun 30, 2023 | -35.86% |
| Mar 31, 2023 | -42.68% |
| Dec 31, 2022 | -44.65% |
| Sep 30, 2022 | -51.05% |
| Jun 30, 2022 | -62.91% |
| Mar 31, 2022 | -62.95% |
| Dec 31, 2021 | -78.00% |
| Sep 30, 2021 | -86.26% |
| Jun 30, 2021 | -69.77% |